J B Chemicals & Pharmaceuticals has received the Establishment Inspection Report from the US FDA for the Company's newly set up and commissioned solid oral dosage forms formulations manufacturing facility at Panoli, Gujarat. The US FDA issues an EIR to the Company when an inspection is satisfactorily "closed".
The said inspection was carried out from 24 June to 28 June 2019. At the end of the inspection, "No Objectionable Observation" were found and no Form 483 was issued.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)